Add BrightSurf on Google Email

Disappointment alters brain chemistry and behavior

A mouse study by Okinawa Institute of Science and Technology researchers has found that acetylcholine release is essential for breaking habits and enabling new choices to be made. The study's findings may help understand diseases such as Parkinson's disease, addiction, and obsessive-compulsive disorder.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalNature Communications·TypeExperimental study·DateDec 17, 2025

Chinese Neurosurgical Journal study explores the role of a combined therapy in Parkinson’s disease treatment

Researchers investigated a combination of stem cell therapy and BDNF enhancement to treat Parkinson's disease. The strategy aims to promote neuroregeneration and functional recovery by introducing progenitor cells genetically matched to the donors, while upregulating BDNF to mitigate neuronal loss and enhance motor function.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateDec 16, 2025

FAU engineers decode dementia type using AI and EEG brainwave analysis

Researchers at Florida Atlantic University have developed a deep learning model that detects and evaluates Alzheimer's disease (AD) and frontotemporal dementia (FTD) using EEG brainwave analysis. The model achieved over 90% accuracy in distinguishing individuals with dementia from cognitively normal participants.

SourceFlorida Atlantic University·JournalBiomedical Signal Processing and Control·TypeComputational simulation/modeling·DateDec 10, 2025

Researchers develop AI Tool to identify undiagnosed Alzheimer's cases while reducing disparities

Researchers developed an AI tool to identify patients with undiagnosed Alzheimer's disease using electronic health records, addressing underdiagnosis and healthcare inequities. The model achieved sensitivity rates of 77-81% across diverse populations, promoting fairness while maintaining high accuracy.

Researchers develop models to help diagnose ALS earlier through blood biomarkers

Scientists at Michigan Medicine have developed machine learning models that can analyze blood samples for biomarkers to detect ALS earlier and predict disease severity. The models show promising results, with predictions accurate up to 91% in some cases, and could lead to improved diagnostic accuracy and treatment options.

SourceMichigan Medicine - University of Michigan·JournalNature Communications·TypeComputational simulation/modeling·DateDec 10, 2025

New technique maps genetic variants driving neurodegenerative disease risk

A new method developed by Penn State researchers improves the analysis of genetic data, identifying more genes associated with neurodegenerative diseases like Alzheimer's and ALS. The technique, BASIC, integrates both bulk tissue samples and single-cell data to uncover shared genetic effects across different cell types.

SourcePenn State·JournalNature Communications·TypeData/statistical analysis·DateDec 2, 2025

Metabolic roots of memory loss

Researchers identified biological markers of inflammation, liver stress, and early damage to brain cells in young adults with obesity. Low blood levels of choline, essential for liver health and long-term brain function, were also found. These findings suggest that metabolic stress and inflammation may begin far earlier than expected.

SourceArizona State University·JournalAging and Disease·TypeExperimental study·DateNov 25, 2025

The therapeutic target against memory impairments in Down syndrome gains strength

A study published in Alzheimer's & Dementia found that long-term pharmacological treatment improves memory alterations and inflammation in mice models for Down syndrome. The treatment targets the CB1 receptor, which is involved in neuronal connections and memory, and shows positive results even when age-related neurodegeneration is added.

SourceUniversitat Pompeu Fabra - Barcelona·JournalAlzheimer s & Dementia·TypeExperimental study·DateNov 20, 2025

Investigating lithium’s potential role in slowing cognitive decline in Alzheimer’s disease

A systematic review and meta-analysis found that lithium supplementation did not significantly improve cognitive function in individuals with mild cognitive impairment or Alzheimer's disease. Alternative formulations like LIT-O may be a potential alternative to harness lithium's neuroprotective properties more efficiently.

SourceFujita Health University·JournalNeuroscience & Biobehavioral Reviews·TypeMeta-analysis·DateNov 19, 2025

Clogged ‘drains’ in the brain a likely early-warning sign of Alzheimer’s disease, find NTU Singapore scientists

A study by NTU Singapore researchers found that enlarged perivascular spaces, or 'clogged drains', in the brain are a likely early-warning sign of Alzheimer's disease. The condition can be visually identified on routine MRI scans, complementing existing methods to detect Alzheimer's earlier.

SourceNanyang Technological University·JournalNeurology·TypeObservational study·DateNov 18, 2025

Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders

Researchers at UGA engineered a live bacterium to deliver Levodopa steadily from the gut to the brain, alleviating motor deficits in models of Parkinson's disease. This breakthrough could lead to fewer pills, steadier symptom control, and better quality of life for patients.

SourceUniversity of Georgia, College of Veterinary Medicine·JournalCell Host & Microbe·TypeRandomized controlled/clinical trial·DateNov 13, 2025

UT Health San Antonio Center for Brain Health celebrates ‘a new era of hope, healing and discovery’ with ribbon-cutting

The UT Health San Antonio Center for Brain Health is a $100 million facility that brings together clinical care, diagnostics and research under one roof. The center will redefine treatment of conditions including Alzheimer's, dementia, stroke and Parkinson's with multidisciplinary care teams.

Anti-amyloid therapy does not change short-term waste clearance in Alzheimer’s

A study by Osaka Metropolitan University found that lecanemab treatment does not change short-term waste clearance function in Alzheimer's patients. The glymphatic system, which carries away metabolic waste like Aβ, is already damaged in AD patients, and treatment may not be enough to restore lost function.

SourceOsaka Metropolitan University·JournalJournal of Magnetic Resonance Imaging·TypeObservational study·DateNov 11, 2025

NAD⁺ restores memory in Alzheimer’s’ disease models by correcting RNA errors

A new study reveals that increasing NAD⁺ levels corrects RNA splicing mistakes, improving brain function and restoring memory in animal models of Alzheimer's disease. The researchers discovered a previously unidentified pathway involving the protein EVA1C, which plays a crucial role in correcting tau-related neuronal damage.

Newly discovered ‘hook’ in motor protein reveals how neurons deliver cargo with precision

Researchers uncover a unique structural motif in the tail region of kinesin-2 that acts as a molecular 'connector,' allowing the motor to correctly recognize and transport its cargo inside cells. The discovery provides new insights into brain transport and diseases, paving the way for diagnostic and therapeutic approaches.

SourceJuntendo University Research Promotion Center·JournalScience Advances·TypeExperimental study·DateNov 6, 2025

Alzheimer’s Disease can hijack communication between brain and fat tissue, potentially worsening cardiovascular and metabolic health

A recent study from Houston Methodist reveals how Alzheimer's can disrupt the connection between nerves and blood vessels in fat tissue, worsening heart and metabolic conditions. The research highlights a potential link between neurodegeneration and cardiovascular and metabolic disorders.

SourceHouston Methodist·JournalJournal of Lipid Research·TypeExperimental study·DateNov 4, 2025

CTE: More than just head trauma, suggests new study

A new study published in Science finds CTE shares genetic similarities with Alzheimer's disease, including DNA damage and tau protein buildup in the brain. Researchers used single-cell genome sequencing to identify somatic mutations in neurons from patients with CTE, revealing abnormal patterns of damage similar to those seen in AD.

SourceBoston Children's Hospital·JournalScience·DateOct 30, 2025

Small study suggests 40Hz sensory stimulation may benefit some Alzheimer’s patients for years

A small study found that five volunteers with late-onset Alzheimer's disease showed significant improvements in cognitive tests and decreased biomarker tau proteins after two years of receiving 40Hz light and sound stimulation. This suggests that the therapy may slow cognitive decline and have direct biological impacts on Alzheimer's p...

SourcePicower Institute at MIT·JournalAlzheimer s & Dementia·TypeExperimental study·DateOct 27, 2025

Tears could open a new avenue for diagnosing and monitoring eye and neurodegenerative diseases

Tear-derived extracellular vesicles show promise as non-invasive biomarkers for ocular and neurodegenerative diseases. The study highlights their potential to provide valuable information about the eye's health, including processes related to neurodegenerative diseases.

SourceGermans Trias i Pujol Research Institute·JournalExtracellular Vesicles and Circulating Nucleic Acids·TypeLiterature review·DateOct 22, 2025